209 related articles for article (PubMed ID: 9819701)
1. The metabolism of phytanic acid and pristanic acid in man: a review.
Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
[TBL] [Abstract][Full Text] [Related]
2. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
3. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
[TBL] [Abstract][Full Text] [Related]
4. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
5. Human metabolism of phytanic acid and pristanic acid.
Verhoeven NM; Jakobs C
Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
[TBL] [Abstract][Full Text] [Related]
6. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
7. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
Poulos A; Sharp P; Fellenberg AJ; Johnson DW
Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
[TBL] [Abstract][Full Text] [Related]
9. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
Kase BF; Björkhem I
Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
[TBL] [Abstract][Full Text] [Related]
10. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
Pahan K; Khan M; Singh I
J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
[TBL] [Abstract][Full Text] [Related]
11. Intraorganellar localization of CoASH-independent phytanic acid oxidation in human liver peroxisomes.
Pahan K; Singh I
FEBS Lett; 1993 Oct; 333(1-2):154-8. PubMed ID: 8224157
[TBL] [Abstract][Full Text] [Related]
12. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
[TBL] [Abstract][Full Text] [Related]
13. Phytanic acid oxidation: topographical localization of phytanoyl-CoA ligase and transport of phytanic acid into human peroxisomes.
Pahan K; Singh I
J Lipid Res; 1995 May; 36(5):986-97. PubMed ID: 7544821
[TBL] [Abstract][Full Text] [Related]
14. Phytanic acid alpha-oxidation: identification of 2-hydroxyphytanoyl-CoA lyase in rat liver and its localisation in peroxisomes.
Jansen GA; Verhoeven NM; Denis S; Romeijn G; Jakobs C; ten Brink HJ; Wanders RJ
Biochim Biophys Acta; 1999 Sep; 1440(2-3):176-82. PubMed ID: 10521701
[TBL] [Abstract][Full Text] [Related]
15. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
Singh H; Beckman K; Poulos A
J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
[TBL] [Abstract][Full Text] [Related]
16. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Kruska N; Reiser G
Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
[TBL] [Abstract][Full Text] [Related]
17. Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase.
Watkins PA; Howard AE; Gould SJ; Avigan J; Mihalik SJ
J Lipid Res; 1996 Nov; 37(11):2288-95. PubMed ID: 8978480
[TBL] [Abstract][Full Text] [Related]
18. Peroxisomes contain a specific phytanoyl-CoA/pristanoyl-CoA thioesterase acting as a novel auxiliary enzyme in alpha- and beta-oxidation of methyl-branched fatty acids in mouse.
Westin MAK; Hunt MC; Alexson SEH
J Biol Chem; 2007 Sep; 282(37):26707-26716. PubMed ID: 17613526
[TBL] [Abstract][Full Text] [Related]
19. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
Singh I; Pahan K; Singh AK; Barbosa E
J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
[TBL] [Abstract][Full Text] [Related]
20. Phytanic acid metabolism in health and disease.
Wanders RJ; Komen J; Ferdinandusse S
Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]